{"name": "Principia BioPharma",
 "permalink": "principia-biopharma",
 "crunchbase_url": "http://www.crunchbase.com/company/principia-biopharma",
 "homepage_url": "http://www.principiabio.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@principiabio.com",
 "phone_number": "650-416-7700",
 "description": "",
 "created_at": "Tue Oct 30 03:53:47 UTC 2012",
 "updated_at": "Wed Dec 12 07:26:38 UTC 2012",
 "overview": "\u003Cp\u003EPrincipia Biopharma is a private, pre-clinical stage company initially focused on the discovery and development of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. The company expects to submit an IND for its lead program in 2013 and continues to invest in additional programs and its reversible covalent platform.  \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       31],
      "assets/images/resized/0021/7842/217842v1-max-150x150.jpg"],
     [[250,
       52],
      "assets/images/resized/0021/7842/217842v1-max-250x250.jpg"],
     [[394,
       82],
      "assets/images/resized/0021/7842/217842v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$12.5M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://www.bizjournals.com/sacramento/prnewswire/press_releases/California/2012/10/29/NY01747",
    "source_description": "Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team",
    "raised_amount": 12500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2012,
    "funded_month": 10,
    "funded_day": 29,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "New Leaf Venture Partners",
         "permalink": "new-leaf-venture-partners-2",
         "image":
          {"available_sizes":
            [[[150,
               39],
              "assets/images/resized/0004/2730/42730v1-max-150x150.png"],
             [[250,
               66],
              "assets/images/resized/0004/2730/42730v1-max-250x250.png"],
             [[257,
               68],
              "assets/images/resized/0004/2730/42730v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "OrbiMed Advisors",
         "permalink": "orbimed-advisors",
         "image":
          {"available_sizes":
            [[[150,
               42],
              "assets/images/resized/0005/0248/50248v1-max-150x150.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-250x250.png"],
             [[203,
               58],
              "assets/images/resized/0005/0248/50248v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Morgenthaler Ventures",
         "permalink": "morgenthaler-ventures",
         "image":
          {"available_sizes":
            [[[150,
               73],
              "assets/images/resized/0001/2347/12347v1-max-150x150.png"],
             [[221,
               108],
              "assets/images/resized/0001/2347/12347v1-max-250x250.png"],
             [[221,
               108],
              "assets/images/resized/0001/2347/12347v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "SR One",
         "permalink": "sr-one",
         "image":
          {"available_sizes":
            [[[150,
               58],
              "assets/images/resized/0004/8794/48794v2-max-150x150.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-250x250.jpg"],
             [[206,
               81],
              "assets/images/resized/0004/8794/48794v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Mission Bay Capital",
         "permalink": "mission-bay-capital-llc",
         "image":
          {"available_sizes":
            [[[150,
               36],
              "assets/images/resized/0025/7471/257471v1-max-150x150.png"],
             [[250,
               60],
              "assets/images/resized/0025/7471/257471v1-max-250x250.png"],
             [[342,
               83],
              "assets/images/resized/0025/7471/257471v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "400 East Jamie Court",
    "address2": "Suite 302",
    "zip_code": "94080",
    "city": "South San Francisco",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.6490544,
    "longitude": -122.3871092}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        125],
       "assets/images/resized/0021/7843/217843v1-max-150x150.jpg"],
      [[250,
        209],
       "assets/images/resized/0021/7843/217843v1-max-250x250.jpg"],
      [[450,
        376],
       "assets/images/resized/0021/7843/217843v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}